1. No category

Point Of Care | PoC Diagnostics Market To Be Worth Over
$30.9 Billion By 2024
Point of Care (POC) testing is medical diagnostic testing performed outside the
clinical laboratory in close proximity to where the patient is receiving care. It is
typically performed by non-laboratory personnel and the results are used for clinical
decision making. The factors such as rising prevalence of diseases resulting in
subsequent increase in demand for better treatment and rapid diagnostic services,
and staff shortages in clinical laboratories are primarily driving the demand for POC
diagnostics.
The report states that lateral flow assays (immunochromatography tests/lateral flow
immunoassays) platform accounts for the largest share of the total point of care
diagnostics market. However, point of care molecular diagnostics tests are expected to
grow at a fastest CAGR of 13.3% from 2018 to 2024. Meticulous Research® anticipated
as to why this area is emerging as the largest use of the platform: “The shift from the
traditional microbiology-based testing to molecular testing stems from the rising
antibiotic resistance crisis, and faster turnaround time of POC molecular assay tests.”
Browse in-depth Report on https://www.meticulousresearch.com/product/point-of-care-diagnostics-pocmarket/
Over-the-Counter (OTC) testing is cited as the major trend driving the growth of point
of care diagnostics market. OTC testing kits are expected to generate relatively higher
revenue than prescription tests over the forecast period owing to the associated ease
of usage, growing home care and self-testing, and higher availability and greater
adoption rate.
On the basis of product type, blood glucose monitoring testing currently dominates
the global POC diagnostics market; however, infectious diseases testing kits segment
is expected to register growth during the forecast period. Influenza causes 12,00050,000 deaths annually in the U.S. Rapid testing for influenza A and B allows for
accurate and timely treatment, as patients only have a 48-hour window to receive
critical antiviral therapy. Thus, growing prevalence of infectious diseases and need for
rapid testing and treatment provide robust opportunities for POC testing companies
like BD, Quidel, Roche, and Alere (Abbott). Meticulous Research ® help companies
operating in POC diagnostics market to identify key growth segments to invest in.
Request for a sample of this research report @ https://www.meticulousresearch.com/download-sample-report/cp_id=4871
Finally, the report states that North America is currently the home of most of the point
of care diagnostics companies. However, Asia-Pacific is named as the area expected to
grow most by 2024. Major reasons cited for this rising demand include accelerated
growth of the economies; relatively lower availability of sophisticated central
laboratory testing services; a larger population base in need for clinical testing;
increasing incidence of infectious and non-communicable diseases in aging
population; and improving availability and awareness of POC tests.
The key players operating in the global point of care diagnostics market are Abbott
Laboratories, AccuBioTech Co., Ltd., Becton Dickinson and Company, Chembio
Diagnostic Systems, Inc., Danaher Corporation, EKF Diagnostics Holdings plc,
WerfenLife, S.A., Johnson and Johnson Service, Inc., Nova Biomedical, F. HoffmannLa Roche Ltd, Sekisui Diagnostics LLC, Quidel Corporation, Siemens AG, and Trinity
Biotech, among others.
Contact Info:
Meticulous Market Research Pvt. Ltd.
Khushal
Email: sales@meticulousresearch.com
Contact Sales- +91-744-7780008
healthcare, connectivity technology, global, market, research, report,
medical devices, medical equipments